Azstarys

Chemical Nameserdexmethylphenidate and dexmethylphenidate
Dosage FormCapsule (oral; serdexmethylphenidate/dexmethylphenidate: 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg)
Drug ClassMiscellaneous
SystemNervous
CompanyCorium, Inc.
Approval Year2021

Indication

  • Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.
Last updated on 6/10/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Azstarys (serdexmethylphenidate and dexmethylphenidate) Prescribing Information2021Corium, Inc. Grand Rapids, MI